• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Advanced Proteome Therapeutics moves into Johnson & Johnson’s Innovation lab

May 1, 2017 By Sarah Faulkner

Johnson & Johnson Innovation Labs in Toronto
Credit: JLabs @ Toronto

Boston-based biotech Advanced Proteome Therapeutics (CVE:APC) said today that it is moving into Johnson & Johnson‘s (NYSE:JNJ) Innovation lab, JLabs, in Toronto.

The 40,000 square-foot incubator is home to a number of life science start-up companies, including Avrobio and Immune Biosolutions. Johnson & Johnson Innovation doesn’t take an equity stake in the companies occupying its lab space, but the start-ups can initiate external partnerships with Johnson & Johnson or other companies.

“Being selected by the Johnson & Johnson Innovation team to join JLabs @ Toronto and locating among a talented and diverse peer group is both an honour and extremely validating for our company,” CEO Randal Chase said in prepared remarks. “The work space and facilities allow us to continue advancing our research while being surrounded by fast growing and emerging companies.”

Advanced Proteome Therapeutics is developing antibody-drug conjugates to target cancerous tumors while avoiding healthy cells. The company said it is working to streamline the process by which these cancer-killing agents are prepared, since traditional methods are cumbersome.

Filed Under: Featured, Oncology, Wall Street Beat Tagged With: advancedproteometherapeutics, johnsonandjohnson

IN CASE YOU MISSED IT

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance
  • Rapid Dose closes first tranche of $5M financing

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS